Book contents
- Prescriber’s Guide – Children and Adolescents
- Prescriber’s Guide – Children and Adolescents
- Copyright page
- Contents
- Introduction
- List of icons
- Amphetamine-D
- Amphetamine-D,L
- Aripiprazole
- Asenapine
- Atomoxetine
- Bupropion
- Chlorpromazine
- Citalopram
- Clomipramine
- Clonidine
- Clozapine
- Duloxetine
- Escitalopram
- Fluoxetine
- Fluphenazine
- Fluvoxamine
- Guanfacine
- Haloperidol
- Lisdexamfetamine
- Lithium
- Lurasidone
- Methylphenidate-D
- Methylphenidate-D,L
- Olanzapine
- Paliperidone
- Paroxetine
- Pimozide
- Quetiapine
- Risperidone
- Sertraline
- Trazodone
- Valproate
- Venlafaxine
- Index by drug name (trade names and generic names)
- Index by use
- Index by class
- Abbreviations
- Endmatter
- References
Quetiapine
Published online by Cambridge University Press: 19 October 2021
Book contents
- Prescriber’s Guide – Children and Adolescents
- Prescriber’s Guide – Children and Adolescents
- Copyright page
- Contents
- Introduction
- List of icons
- Amphetamine-D
- Amphetamine-D,L
- Aripiprazole
- Asenapine
- Atomoxetine
- Bupropion
- Chlorpromazine
- Citalopram
- Clomipramine
- Clonidine
- Clozapine
- Duloxetine
- Escitalopram
- Fluoxetine
- Fluphenazine
- Fluvoxamine
- Guanfacine
- Haloperidol
- Lisdexamfetamine
- Lithium
- Lurasidone
- Methylphenidate-D
- Methylphenidate-D,L
- Olanzapine
- Paliperidone
- Paroxetine
- Pimozide
- Quetiapine
- Risperidone
- Sertraline
- Trazodone
- Valproate
- Venlafaxine
- Index by drug name (trade names and generic names)
- Index by use
- Index by class
- Abbreviations
- Endmatter
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Prescriber's Guide – Children and AdolescentsStahl's Essential Psychopharmacology, pp. 409 - 422Publisher: Cambridge University PressPrint publication year: 2018
References
Suggested Reading
Findling, RL, McKenna, K, Early, WR et al. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 2012;22(5):327–42.Google Scholar
Findling, RL, Pathak, S, Earley, WR et al. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 2014;24(6):325–35.CrossRefGoogle ScholarPubMed
Pathak, S, Findling, RL, Earley, WR et al. Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial. J Clin Psychiatry 2013;74(1):e100–09.Google Scholar
Pillay, J, Boylan, K, Carrey, N et al. First- and second-generation antipsychotics in children and young adults: systematic review update [internet]. Comparative Effectiveness Reviews. AHRQ Publication No. 17-EHC001-EF. Rockville, MD: Agency for Healthcare Research and Quality; March 2017.Google Scholar